IL1B and cancer: In the first scenario, MDI (which consisted of a total dose of 10 Gy in five daily fractions) led to reduced mRNA expression of some proinflammatory markers (such as CCR7 and IL1β), with no changes documented for anti-inflammatory markers, while cancer cell invasion and migration were promoted.